|
ATCC
c haemolyticum dsm 19808t C Haemolyticum Dsm 19808t, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/c haemolyticum dsm 19808t/product/ATCC Average 91 stars, based on 1 article reviews
c haemolyticum dsm 19808t - by Bioz Stars,
2026-06
91/100 stars
|
Buy from Supplier |
|
ATCC
mwu142217t Mwu142217t, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mwu142217t/product/ATCC Average 91 stars, based on 1 article reviews
mwu142217t - by Bioz Stars,
2026-06
91/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
antibody against mbd2 ![]() Antibody Against Mbd2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/antibody against mbd2/product/Cell Signaling Technology Inc Average 96 stars, based on 1 article reviews
antibody against mbd2 - by Bioz Stars,
2026-06
96/100 stars
|
Buy from Supplier |
|
ATCC
m75054 92 0 pasteurella testudinis ![]() M75054 92 0 Pasteurella Testudinis, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/m75054 92 0 pasteurella testudinis/product/ATCC Average 90 stars, based on 1 article reviews
m75054 92 0 pasteurella testudinis - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Esoterix Genetic Laboratories
molecular endocrinology, research and development ![]() Molecular Endocrinology, Research And Development, supplied by Esoterix Genetic Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/molecular endocrinology, research and development/product/Esoterix Genetic Laboratories Average 90 stars, based on 1 article reviews
molecular endocrinology, research and development - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
ATCC
atcc 19803 ![]() Atcc 19803, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/atcc 19803/product/ATCC Average 94 stars, based on 1 article reviews
atcc 19803 - by Bioz Stars,
2026-06
94/100 stars
|
Buy from Supplier |
|
NCIMB Ltd
strain 134t ![]() Strain 134t, supplied by NCIMB Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/strain 134t/product/NCIMB Ltd Average 90 stars, based on 1 article reviews
strain 134t - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Addgene inc
rrid addgene 208875 rrid addgene 187830 rrid addgene 198033 ![]() Rrid Addgene 208875 Rrid Addgene 187830 Rrid Addgene 198033, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rrid addgene 208875 rrid addgene 187830 rrid addgene 198033/product/Addgene inc Average 92 stars, based on 1 article reviews
rrid addgene 208875 rrid addgene 187830 rrid addgene 198033 - by Bioz Stars,
2026-06
92/100 stars
|
Buy from Supplier |
|
AstraZeneca ltd
xylocaine jelly 2 ![]() Xylocaine Jelly 2, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/xylocaine jelly 2/product/AstraZeneca ltd Average 90 stars, based on 1 article reviews
xylocaine jelly 2 - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
Bio-Techne corporation
nbp1-19803 ![]() Nbp1 19803, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/nbp1-19803/product/Bio-Techne corporation Average 90 stars, based on 1 article reviews
nbp1-19803 - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
AstraZeneca ltd
dmpk, crdl 1st 1800 concord pike wilmington, de 19803 ![]() Dmpk, Crdl 1st 1800 Concord Pike Wilmington, De 19803, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dmpk, crdl 1st 1800 concord pike wilmington, de 19803/product/AstraZeneca ltd Average 90 stars, based on 1 article reviews
dmpk, crdl 1st 1800 concord pike wilmington, de 19803 - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS Pathogens
Article Title: Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
doi: 10.1371/journal.ppat.1000495
Figure Lengend Snippet: (A) Latent HIV-1 reactivation in J-Lat 6.3 cells after transfection with the indicated expression plasmids and flow cytometry. Percent GFP-positive cells after gating for tomato-positive cells is shown. Experiment was performed in triplicate and error bars represent standard deviation. (B) Transcriptional activation of latent HIV-1 in J-Lat 6.3 after transfection with a siRNA that targets MBD2. Levels of MBD2 (left panel) or HIV-1 (right panel) mRNA were determined by reverse transcription and quantitative PCR and normalized to those after transfection with a non-targeting control siRNA. Data are representative of three different experiments. Error bars indicate standard deviation of qPCR results. (C) Flow cytometry of GFP expression in 293T cells that were mock transfected, transfected with methylated pEGFP-N1 (meGFP), or with unmethylated pEGFP-N1 (GFP). Gate indicates GFP-positive cells. (D) Flow cytometry of GFP expression in 293T cells cotransfected with methylated pEGFP-N1 (left panel) or unmethylated pEGFP-N1 (right panel) and an expression vector marked by the tomato fluorescent protein. Tomato-positive cells were gated to measure GFP expression in populations that received a control vector lacking an insert or one that encodes MBD2 1345–1947 . Gates indicate GFP-positive cells.
Article Snippet: Lysates were incubated overnight with 5 μg of
Techniques: Transfection, Expressing, Flow Cytometry, Standard Deviation, Activation Assay, Reverse Transcription, Real-time Polymerase Chain Reaction, Control, Methylation, Plasmid Preparation
Journal: PLoS Pathogens
Article Title: Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
doi: 10.1371/journal.ppat.1000495
Figure Lengend Snippet: (A) Bisulfite-mediated methylcytosine mapping of HIV-1 in J-Lat 6.3 cells treated with PBS (left panel) or aza-CdR (right panel). Asterisks indicate cytosines with a statistically significant lesser level of methylation in cells treated with aza-CdR. (B) Panel 1: Chromatin immunoprecipitation analysis of MBD2 recruitment to an unrelated DNA sequence between the β-actin and fascin-1 genes (unrelated), HIV-1 CpG island 1 (CpG1), and HIV-1 CpG island 2 (CpG2). Panels 2–4: Chromatin immunoprecipitation analysis of MBD2, HDAC2, or Sp1 recruitment to CpG island 2 in cells treated with PBS or aza-CdR. Data are representative of three independent experiments. Error bars indicate standard deviation of quantitative PCR results. (C) Flow cytometric analysis of latent HIV-1 reactivation in the indicated J-Lat clones after treatment with aza-CdR, TNF-α, or aza-CdR plus TNF-α. Histograms indicate GFP fluorescence. Gates indicate GFP-positive cells. (D) Bar graph representation of reactivation data. HIV-1 expression was normalized to control cells treated with PBS, and either GFP fluorescence (top panel) or percentage of GFP-positive cells (bottom panel) is displayed. Results are representative of three independent experiments. (E) Latent HIV-1 reactivation in J-Lat 6.3 treated with increasing doses of aza-CdR alone, in combination with TNF-α, or in combination with prostratin. Data points on the y-axis represent fluorescence at 0 uM Aza-CdR. GFP fluorescence was measured by flow cytometry and normalized to control cells treated with PBS. Error bars indicate standard deviation of three experiments. (F) Latent HIV-1 reactivation in the J-Lat cell line A2 treated with aza-CdR, TNF-α, or aza-CdR plus TNF-α. Gate indicates GFP-positive cells.
Article Snippet: Lysates were incubated overnight with 5 μg of
Techniques: Methylation, Chromatin Immunoprecipitation, Sequencing, Standard Deviation, Real-time Polymerase Chain Reaction, Clone Assay, Fluorescence, Expressing, Control, Flow Cytometry
Journal: PLoS Pathogens
Article Title: Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation
doi: 10.1371/journal.ppat.1000495
Figure Lengend Snippet: The first 821 nucleotides of the HIV-1 genome are shown, with genome position indicated relative to transcriptional start site. The virus promoter is comprised of the U3, R, and U5 regions. CpG island 2 is indicated by vertical lines, and filled circles on top of lines indicate methyl groups. Arrow indicates HIV-1 transcriptional start site. (A) Transcriptional repression during HIV-1 latency. Sequence-specific factors recruit HDAC1. CpG island 2 is methylated and bound by MBD2, which mediates transcriptional repression by recruitment of NuRD. (B) NF-κB activation triggers loss of p50 homodimers and CBF-1 from the HIV-1 promoter, resulting in decreased HDAC recruitment and partial reactivation of latent virus. Increased RelA (p65) recruitment has also been reported. Effects upon Yin-Yang 1 recruitment are unknown. (C) Treatment with aza-CdR decreases methylation of HIV-1 CpG islands, leading to a loss of MBD2 from the HIV-1 promoter. Latent virus is partially reactivated by removal of the methylation block. (D) Potent, synergistic reactivation of latent virus when NF-κB activation is combined with aza-CdR treatment. This occurs via loss of NF-κB-responsive transcriptional repressors and MBD2 from the HIV-1 promoter.
Article Snippet: Lysates were incubated overnight with 5 μg of
Techniques: Virus, Sequencing, Methylation, Activation Assay, Blocking Assay